MCID: RCR004
MIFTS: 42

Recurrent Respiratory Papillomatosis malady

Categories: Rare diseases, Respiratory diseases

Aliases & Classifications for Recurrent Respiratory Papillomatosis

About this section
Sources:
46NIH Rare Diseases, 52Orphanet, 66UMLS, 38MESH via Orphanet, 67UMLS via Orphanet
See all MalaCards sources

Aliases & Descriptions for Recurrent Respiratory Papillomatosis:

Name: Recurrent Respiratory Papillomatosis 46 52 66
Juvenile-Onset Recurrent Respiratory Papillomatosis 46
Adult-Onset Recurrent Respiratory Papillomatosis 46
Respiratory Papillomatosis, Recurrent 46
Laryngeal Papilloma, Recurrent 46
 
Juvenile Laryngeal Papilloma 46
Jorrp 46
Aorrp 46
Rrp 46

Characteristics:

Orphanet epidemiological data:

52
recurrent respiratory papillomatosis:
Age of onset: Adolescent,Adult,Childhood

Classifications:



External Ids:

Orphanet52 ORPHA60032
MESH via Orphanet38 C535297
UMLS via Orphanet67 C1168198

Summaries for Recurrent Respiratory Papillomatosis

About this section
NIH Rare Diseases:46 Recurrent respiratory papillomatosis (rrp) is a rare viral disease where tumors (papillomas) grow in the air passages leading from the nose and mouth into the lungs (respiratory tract). although the tumors can grow anywhere in the respiratory tract, their presence in the larynx (voice box) causes the most frequent problems, a condition called laryngeal papillomatosis. the tumors may vary in size and grow very quickly. they often grow back even when removed. rrp is caused by two types of human papillomavirus (hpv), called hpv 6 and hpv 11. last updated: 11/21/2011

MalaCards based summary: Recurrent Respiratory Papillomatosis, also known as juvenile-onset recurrent respiratory papillomatosis, is related to fruit allergy and wolffian duct adenocarcinoma. An important gene associated with Recurrent Respiratory Papillomatosis is HLA-DRB1 (Major Histocompatibility Complex, Class II, DR Beta 1), and among its related pathways are Staphylococcus aureus infection and CTLA4 Signaling. Affiliated tissues include lung, t cells and testes.

Related Diseases for Recurrent Respiratory Papillomatosis

About this section

Diseases related to Recurrent Respiratory Papillomatosis via text searches within MalaCards or GeneCards Suite gene sharing:

(show top 50)    (show all 95)
idRelated DiseaseScoreTop Affiliating Genes
1fruit allergy10.5HLA-DQB1, HLA-DRB1
2wolffian duct adenocarcinoma10.5HLA-DQB1, HLA-DRB1
3quinquaud's decalvans folliculitis10.5HLA-DQB1, HLA-DRB1
4parsonage turner syndrome10.5HLA-DQB1, HLA-DRB1
5pediatric systemic lupus erythematosus10.5HLA-DQB1, HLA-DRB1
6myopathy-growth delay-intellectual disability-hypospadias syndrome10.5HLA-DQB1, HLA-DRB1
7krieble bixler syndrome10.5HLA-DQB1, HLA-DRB1
8limb dystonia10.5HLA-DQB1, HLA-DRB1
9spondylarthropathy10.5HLA-DQB1, HLA-DRB1
10rheumatic myocarditis10.5HLA-DQB1, HLA-DRB1
11nebulin-related early-onset distal myopathy10.5HLA-DQB1, HLA-DRB1
12purpura fulminans10.5HLA-DQB1, HLA-DRB1
13lymphocytic colitis10.5HLA-DQB1, HLA-DRB1
14autoinflammation, lipodystrophy, and dermatosis syndrome10.5HLA-DQB1, HLA-DRB1
15peripheral t-cell lymphoma10.5HLA-DQB1, HLA-DRB1
16thrombocytopenia due to platelet alloimmunization10.5HLA-DQB1, HLA-DRB1
17orbit alveolar rhabdomyosarcoma10.5HLA-DQB1, HLA-DRB1
18idiopathic central precocious puberty10.4HLA-DQB1, HLA-DRB1
19oculogyric crisis10.4HLA-DQB1, HLA-DRB1
20mononeuritis of upper limb10.4HLA-DQB1, HLA-DRB1
21hypoxia10.4HLA-DQB1, HLA-DRB1
22anthracosilicosis10.4HLA-DRB1, IL2
23epidermolysis bullosa simplex superficialis10.4HLA-DQB1, HLA-DRB1
24cervical benign neoplasm10.4EGFR, HLA-DRB1
25achilles bursitis10.4HLA-DQB1, HLA-DRB1
26skin sarcoidosis10.3HLA-DRB1, IL2
27papilloma10.3
28respiratory system disease10.3HLA-DRB1, IL2
29childhood type dermatomyositis10.3EGFR, HLA-DRB1
30renovascular hypertension10.3HLA-DRB1, IL2
31subcorneal pustular dermatosis10.3HLA-DQB1, HLA-DRB1
32iridocyclitis10.3HLA-DRB1, IL2
33laryngeal papillomatosis10.3
34early congenital syphilis10.2EGFR, IL2
35subendocardial infarction acute myocardial infarction10.2HLA-DQB1, IL2
36hereditary conventional renal cell carcinoma10.2HLA-DRB1, IL2
37kernicterus10.2HLA-DRB1, IL2
38laryngitis10.1
39progressive locomotor ataxia10.1HLA-B, HLA-DRB1
40common variable immunodeficiency10.1HLA-B, HLA-DRB1
41xanthomatosis10.1HLA-DRB1, IL2
42epstein-barr virus hepatitis10.1HLA-B, HLA-DRB1
43hypercementosis10.1HLA-B, HLA-DRB1
44hernia of ovary and fallopian tube10.1HLA-B, HLA-DRB1
45mixed lacrimal gland cancer10.1HLA-DRB1, IL2
46potato nose10.1HLA-B, HLA-DRB1
47duodenal benign neoplasm10.1HLA-B, HLA-DRB1
48hemophagocytic lymphohistiocytosis10.0HLA-B, HLA-DRB1
49selective igm deficiency disease10.0HLA-B, HLA-DQB1
50multiple sclerosis, disease progression, modifier of10.0HLA-DQB1, HLA-DRB1, IL2

Graphical network of the top 20 diseases related to Recurrent Respiratory Papillomatosis:



Diseases related to recurrent respiratory papillomatosis

Symptoms for Recurrent Respiratory Papillomatosis

About this section

Drugs & Therapeutics for Recurrent Respiratory Papillomatosis

About this section

Drugs for Recurrent Respiratory Papillomatosis (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show all 8)
idNameStatusPhaseClinical TrialsCas NumberPubChem Id
1
CidofovirPhase 4, Phase 2, Phase 131113852-37-260613
Synonyms:
(2S)-3-Hydroxy-2-phosphonylmethoxypropyl-cytosine
(S)-(3-(4-amino-2-Oxopyrimidin-1(2H)-yl)-1-hydroxypropan-2-yloxy)methylphosphonic acid
(S)-1-(3-Hydroxy-2-phosphonomethoxypropyl)cytosine
(S)-1-[3-Hydroxy-2-(phosphonomethoxy)propyl]cytosine
(S)-1-[3-Hydroxy-2-(phosphonylmethoxy)propyl]cytosine
(S)-1-[3-hydroxy-2-(phosphonylmethoxy)-propyl]cytosine
(S)-2-(4-Amino-2-oxo-1(2H)-pyrimidinyl-1-(hydroxymethyl)ethoxy)methyl phosphonic acid
(S)-HPMPC
(s)-[[2-(4-amino-2-oxo-1(2h)-pyrimidinyl)-1-(hydroxymethyl)ethoxy]methyl]phosphonic acid
({[(2S)-1-(4-amino-2-oxopyrimidin-1(2H)-yl)-3-hydroxypropan-2-yl]oxy}methyl)phosphonic acid
({[(S)-1-(4-amino-2-oxo-1,2-dihydropyrimidin-1-yl)-3-hydroxypropan-2-yl]oxy}methyl)phosphonic acid
1-(3-hydroxy-2-phosphonylmethoxypropyl)cytosine
1-(S)-[3-Hydroxy-2-(phosphonomethoxy)propyl]cytosine
1-[(S)-3-Hydroxy-2-(phosphonomethoxy)propyl]-cytosine dihydrate
1-[(S)-3-Hydroxy-2-(phosphonomethoxy)propyl]cytosine
113852-37-2
120362-37-0 (hydrochloride salt)
149394-66-1
AC-1666
AC1L1TLB
AC1Q6C68
AKOS005145721
C8H14N3O6P
CDV
CHEBI:3696
 
CHEMBL152
CID60613
Cidofovir
Cidofovir (Vistide)
Cidofovir (anhydrous)
Cidofovir Anhydrous
Cidofovir anhydrous
Cidofovirum
DB00369
Forvade
GS 0504
GS 504
GS-0504
GS-504
GS504
HPMPC
HSDB 7115
LS-106432
MolPort-005-935-597
NSC742135
S1516_Selleck
UNII-768M1V522C
Vistide
Vistide, Cidofovir
[(2S)-1-(4-amino-2-oxopyrimidin-1-yl)-3-hydroxypropan-2-yl]oxymethylphosphonic acid
[(S)-2-(4-Amino-2-oxo-2H-pyrimidin-1-yl)-1-hydroxymethyl-ethoxymethyl]-phosphonic acid
[[(S)-2-(4-amino-2-oxo-1(2H)-pyrimidinyl)-1-(hydroxymethyl)ethoxy]methyl]phosphonic acid
2
BevacizumabPhase 2, Phase 11938216974-75-3
Synonyms:
216974-75-3
Avastin
Avastin (TN)
Bevacizumab
Bevacizumab (genetical recombination)
 
Bevacizumab (genetical recombination) (JAN)
D06409
R-435
anti-VEGF monoclonal antibody
antiVEGF
bevacizumab
3
CelecoxibPhase 2427169590-42-52662
Synonyms:
169590-42-5
184007-95-2
1oq5
4-(5-(4-Methylphenyl)-3-(trifluoromethyl)-1H-pyrazol-1-yl)benzenesulfonamide
4-[5-(4-METHYLPHENYL)-3-(TRIFLUOROMETHYL)-1H-PYRAZOL-1-YL]BENZENESULFONAMIDE
4-[5-(4-methylphenyl)-3-(trifluoromethyl)-1Hpyrazol-1-yl] benzenesulfonamide
4-[5-(4-methylphenyl)-3-(trifluoromethyl)pyrazol-1-yl]benzenesulfonamide
AC-4228
AC1L1E6K
AI-525
BIDD:GT0408
BRD-K02637541-001-02-4
BSPBio_003596
Benzenesulfonamide,4-(5-(4-methylphenyl)-3-(trifluoromethyl)-1H-pyrazol-1-yl)
C07589
C105934
C17H14F3N3O2S
CCRIS 8679
CEL
CEP-33222
CHEBI:41423
CHEMBL118
CID2662
CPD000550473
Celebra
Celebrex
Celebrex (TN)
Celebrex, Celebra, Celecoxib
Celecox
Celecoxi
Celecoxib
Celecoxib (JAN/USAN/INN)
Celecoxib (SC-58635)
Celecoxib [Old RN]
Celecoxib [USAN]
Celecoxibum
Celocoxib
Célécoxib
D00567
DB00482
DivK1c_000893
Eurocox
FT-0080064
HMS1922G14
HMS2089L18
HMS2093I07
HMS502M15
HSDB 7038
I01-1033
IDI1_000893
KBio1_000893
KBio2_000912
 
KBio2_002351
KBio2_003480
KBio2_004919
KBio2_006048
KBio2_007487
KBio3_002830
KBio3_003037
KBioGR_000723
KBioGR_002351
KBioSS_000912
KBioSS_002354
LS-31667
MLS001165684
MLS001195656
MLS001304708
Medicoxib
MolPort-002-885-815
NCGC00091455-01
NCGC00091455-02
NCGC00091455-03
NCGC00091455-04
NCI60_041049
NINDS_000893
NSC719627
Onsenal
P-(5-P-Tolyl-3-(trifluoromethyl)pyrazol-1-yl)benzenesulfonamide
Pfizer brand of celecoxib
S1261_Selleck
SAM002589995
SC 58635
SC-58553, SC-58635
SC-58635
SC58635
SMR000550473
SPBio_001512
SPECTRUM1503678
Solexa
Spectrum2_001576
Spectrum3_001996
Spectrum4_000182
Spectrum5_001324
Spectrum_000432
TL8001323
TPI-336
UNM-0000305813
Xilebao
YM 177
YM-177
YM177
ZINC02570895
cMAP_000027
celecoxib
p-(5-p-Tolyl-3-(trifluoromethyl)pyrazol-1-yl)benzenesulfonamide
4
pembrolizumabPhase 23551374853-91-4
Synonyms:
Keytruda
 
MK-3475
lambrolizumab
5retinolNutraceuticalPhase 2450
6
Vitamin ANutraceuticalPhase 245011103-57-4, 68-26-8445354
Synonyms:
(2E,4E,6E,8E)-3,7-dimethyl-9-(2,6,6-trimethylcyclohex-1-en-1-yl)nona-2,4,6,8-tetraen-1-ol
(2E,4E,6E,8E)-3,7-dimethyl-9-(2,6,6-trimethylcyclohexen-1-yl)nona-2,4,6,8-tetraen-1-ol
(all-E)-3,7-Dimethyl-9-(2,6,6-trimethyl-1-cyclohexen-1-yl)-2,4,6,8-nonatetraen-1-ol
.alpha.lin
.alpha.sterol
.beta.-Retinol
11103-57-4
13123-33-6
1341-18-0
1406-67-3
17104-91-5
1rbp
3,7-Dimethyl-9-(2,6,6-trimethyl-1-cyclchexen-1-yl)-2,4,6,8-nonatetraen-1-ol
3,7-Dimethyl-9-(2,6,6-trimethyl-1-cyclohexen-1-yl)-2,4,6,8-nonate-traen-1-ol
3,7-Dimethyl-9-(2,6,6-trimethyl-1-cyclohexen-1-yl)-2,4,6,8-nonatetraen-1-ol
3,7-Dimethyl-9-(2,6,6-trimethyl-1-cyclohexenyl)-2,4,6,8-nonatetraen-1-ol
3,7-dimethyl-9-(2,6,6-trimethyl-1-cyclohexen-1-yl)-2,4,6,8-nonatetraen-1-ol, (all-E)-Isomer
4-06-00-04133 (Beilstein Handbook Reference)
53637-36-8
5979-23-7
68-26-8
95144_FLUKA
95144_SIGMA
95146_FLUKA
95146_SIGMA
A-Mulsal
A-Sol
A-Vi-Pel
A-Vitan
AC-11701
AC1L9HU3
AC1Q7BU9
ACON
ALL-TRANS RETINOL (SEE ALSO RETINOID PROJECT 1)
AR-1L3057
ATAV
Afaxin
Agiolan
Agoncal
Alcohol 9,13-dimethyl-7-(1,1,5-trimethyl-6-cyclohexen-5-yl)-7,9,11,13-nonatetraen-15-ol
Alcovit A
All Trans Retinol
All-trans retinol
All-trans-Retinol
Alphalin
Alphasterol
Anatola
Anatola A
Anti-infective vitamin
Antixerophthalmic vitamin
Antixerophthalmisches Vitamin
Aoral
Apexol
Apostavit
Aquasol A Parenteral
Aquasynth
Atars
Avibon
Avita
Avitol
Axerol
Axerophthol
Axerophtholum
BIDD:PXR0102
BRN 0403040
Bentavit A
Biosterol
C00473
C17276
C20H30O
CCRIS 5444
CHEBI:17336
CHEMBL986
CID445354
Chocola A
Cylasphere
D014801
D06543
DB00162
Del-VI-A
Disatabs Tabs
Dofsol
Dohyfral A
EINECS 200-683-7
EINECS 234-328-2
Epiteliol
HMS1921B04
HMS2092L13
HMS501I08
HSDB 815
Hi-A-Vita
Homagenets Aoral
Homagenets aorl
Hydrovit A
IDI1_000486
LMPR01090001
LPK
LS-1578
Lard Factor
M.V.C. 9+3
M.V.I.-12
 
MLS001066379
MLS001074751
MolPort-001-785-962
Mvc Plus
Myvpack
NCGC00091784-01
NCGC00091784-02
NCGC00091784-03
NCGC00091784-04
NCGC00091784-05
NCGC00091784-06
NSC 122759
NSC122759
Nio-A-Let
Oleovitamin A
Ophthalamin
Plivit A
Prepalin
R7632_SIGMA
Retin-11,12-t2-ol (9CI)
Retinol
Retinol [INN:BAN]
Retinol solution
Retinol, all-trans- (8CI)
Retinol-(cellular-retinol-binding-protein)
Retinolo
Retinolo [DCIT]
Retinolum
Retinolum [INN-Latin]
Retrovitamin A
Ro-a-vit
Rovimix A 500
SDCCGMLS-0066724.P001
SMP2_000102
SMR000112036
SPECTRUM1501203
ST057232
Sehkraft A
Solu-A
Spectrum5_000993
Spectrum5_001997
Super A
Testavol
Testavol S
Thalasphere
UNII-81G40H8B0T
UNII-G2SH0XKK91
Vaflol
Vafol
Veroftal
Vi-.alpha.
Vi-Alpha
Vi-Dom-A
Vi-a
Vio-A
Vitamin A
Vitamin A (Feed)
Vitamin A (USP)
Vitamin A alcohol
Vitamin A alcohol (VAN)
Vitamin A cryst
Vitamin A1
Vitamin A1 alcohol
Vitamin A1 alcohol, all trans
Vitamin- A
Vitamin- A alcohol
Vitamin- A alcohol solution
Vitamin- A1
Vitamin-?A
Vitamin-?A alcohol
Vitamin-?A alcohol solution
Vitamin-?A1
Vitamine A
Vitaminum A
Vitavel A
Vitavel-A
Vitpex
Vogan
Vogan-Neu
Vogan-nu
WLN: L6UTJ A1 B1U1Y1&U2U1Y1&U2Q C1 C1
Wachstumsvitamin
ZINC03831417
Zinosan N
[11,12-3H]-Retinol
alin
all-trans-3,7-Dimethyl-9-(2,6,6-trimethyl-1-cyclohexen-1-yl)-2,4,6,8-nonatetraen-1-ol
all-trans-Retinol
all-trans-Retinyl alcohol
all-trans-Vitamin A
all-trans-Vitamin A alcohol
all-trans-Vitamin A1
all-trans-retinol
all-trans-retinyl alcohol
all-trans-vitamin A alcohol
b-Retinol
beta-Retinol
retinol
tROL
trans-Retinol
trans-Retinol acid (Vitamin A)
trans-Vitamin A alcohol
trans-retinol
7vitamin dPhase 11607
8
ErgocalciferolNutraceuticalPhase 1121150-14-65280793
Synonyms:
'Ergosterol irradiated'
(+)-Vitamin D2
(3-beta,5Z,7E,22E)-9,10-Secoergosta-5,7,10,(19),22-tetraen-3-ol
(3S,5Z,7E,14xi,17alpha,22E)-9,10-secoergosta-5,7,10,22-tetraen-3-ol
(3S,5Z,7E,22E)-9,10-secoergosta-5,7,10(19),22-tetraen-3-ol
(3S,5Z,7E,22E)-9,10-secoergosta-5,7,10,22-tetraen-3-ol
(3beta,5Z,7E,22E)-9,10-secoergosta-5,7,10(19),22-tetraen-3-ol
(3beta,5Z,7e,22e)-9,10-Secoergosta-5,7,10(19),22-tetraen-3-ol
(5E,7E,22E)-9,10-Secoergosta-5,7,10,22-tetraen-3-ol
(5Z,7E,22E)-(3S)-9,10-seco-5,7,10(19),22-ergostatetraen-3-ol
(5Z,7E,22E)-(3S)-9,10-secoergosta-5,7,10(19),22-tetraen-3-ol
(5Z,7e,22e)-(3S)-9,10-Seco-5,7,10(19),22-ergostatetraen-3-ol
(5Z,7e,22e)-(3S)-9,10-Secoergosta-5,7,10(19),22-tetraen-3-ol
22-Tetraen 3beta 9,10,Secoergosta-5,7,10(19)-ol
31316-19-5
4-Methylene-3-[2-[tetrahydro-7a-methyl-1-(1,4,5-trimethyl-2-hexenyl)-4(3aH)-indanylidene]ethylidene]-Cyclohexanol
47768_SUPELCO
50-14-6
7489-18-1
7E677DC1-E1C4-4FC5-8F4A-BCE1857F7E87
8017-28-5
9,10,Secoergosta-5,7,10(19),22-tetraen 3.beta.-ol
9,10-Seco(5Z,7E,22E)-5,7,10(19),22-ergostatetraen-3-ol
9,10-Secoergosta-5,7,10(19),22-tetraen-3-beta-ol
9,10-Secoergosta-5,7,10(19),22-tetraen-3b-ol
95220_FLUKA
95220_SIGMA
AC-1355
AC1L1FIE
AC1NQXLH
AC1NS4DE
AC1NS9GI
AC1NSSVD
AC1NWAM3
AC1O5EDK
AC1O6WAM
ACon1_002187
Activated ergosterol
BPBio1_000418
BSPBio_000380
BSPBio_001974
Buco-D
C05441
C28H44O
CALCIFEROL IN A GELATIN MATRIX
CALCIFEROL, U.S.P.
CHEBI:28934
CHEMBL1536
CID11003810
CID3249
CID5280793
CID5315257
CID5353610
CID5356615
CID5702050
CID6432478
CID6536972
Calciferol
Calciferol (TN)
Calciferol (vitamin D2)
Calciferolum
Calciferon 2
Condacaps
Condocaps
Condol
Crtron
Crystallina
D-Arthin
D-Tracetten
D00187
DB00153
Daral
Davitamon D
Davitin
De-rat concentrate
Decaps
Dee-Osterol
Dee-Ron
Dee-Ronal
Dee-Roual
Deltalin
Deratol
Detalup
Diactol
Divit urto
Doral
Drisdol
Drisdol (TN)
E5750_SIGMA
EINECS 200-014-9
Ercalciol
Ergocalciferol
Ergocalciferol (D2)
Ergocalciferol (JP15/USP)
Ergocalciferol [INN:BAN:JAN]
Ergocalciferol oil
Ergocalciferol: Vitamin D
 
Ergocalciferolo
Ergocalciferolo [DCIT]
Ergocalciferols
Ergocalciferolum
Ergocalciferolum [INN-Latin]
Ergorone
Ergosterol activated
Ergosterol irradiated
Ergosterol, irradiated
Ertron
Fortodyl
Geltabs
Geltabs Vitamin D
HMS1920K20
HMS2091B19
HMS502I07
HSDB 819
Haliver
Hi-Deratol
Hyperkil
I05-0022
IDI1_000805
Infron
Irradiated ergosta-5,7,22-trien-3-beta-ol
Irradiated ergosta-5,7,22-trien-3.beta.-ol
Irradiated ergosta-5,7,22-trien-3beta-ol
Irradiated ergosterol
LMST03010001
LMST03010014
LS-3228
MEGxm0_000466
MLS001332467
MLS001332468
Metadee
Mina D2
MolPort-001-740-057
MolPort-001-793-930
MolPort-002-526-645
MolPort-003-666-178
MolPort-006-822-629
Mulsiferol
Mykostin
NCGC00142497-01
NCGC00179579-01
NCGC00179579-02
NSC 62792
NSC62792
Novovitamin-D
Oleovitamin D
Oleovitamin D, Synthetic
Oleovitamin D2
Osteil
Ostelin
Prestwick3_000420
Prestwick_554
Radiostol
Radstein
Radsterin
Rodine C
Rodinec
SMR000857106
SPECTRUM1500276
ST057150
STOCK1N-53397
Shock-ferol
Shock-ferol sterogyl
Sorex C.R
Sorex C.R.
Spectrum5_000666
Sterogyl
Synthetic Vitamin D
UNII-VS041H42XC
Uvesterol D
Uvesterol-D
VITAMIN D2
VITAMIN D2 WATER DISPERSABLE U.S.P.
VITAMIN_D2
Vigantol
Vio D
Vio-D
Viostdrol
Viosterol
Viosterol in Oil
Vitamin D2
Vitamin- D2
Vitamin-?D2
Vitamina D2
Vitavel-D
WLN: L56 FYTJ A1 BY1&1U1Y1&Y1&1 FU2U- BL6YYTJ AU1 DQ
ZINC04474571
ZINC04629876
beta-Ol
bmse000510
component of Geltabs Vitamin D
delta-Arthin
delta-Tracetten
ergocalciferol
vitamin d-2

Interventional clinical trials:

(show all 21)
idNameStatusNCT IDPhase
1Use of Cidofovir for Recurrent Respiratory PapillomatosisCompletedNCT00205374Phase 4
2Interventional Cryotherapy for the Eradication of Benign Airway Disease ("ICE the BAD")TerminatedNCT00747461Phase 4
3Effect of Vaccination in Patients With Recurrent Respiratory PapillomatosisActive, not recruitingNCT01375868Phase 3
44-valent HPV Vaccine to Treat Recurrent Respiratory Papillomatosis in ChildrenNot yet recruitingNCT01995721Phase 3
5Propranolol Administration in Pediatric Patients With Recurrent Respiratory PapillomatosisWithdrawnNCT01058317Phase 2, Phase 3
6A Trial Study of SGN-00101 in Treating Pediatric Patients With Recurrent Respiratory PapillomatosisCompletedNCT00038714Phase 2
7Study of Celebrex (Celecoxib) in Patients With Recurrent Respiratory PapillomatosisCompletedNCT00571701Phase 2
8Bevacizumab Versus Cidofovir for the Treatment of Recurrent Respiratory PapillomatosisRecruitingNCT02555800Phase 2
9Avelumab for People With Recurrent Respiratory PapillomatosisRecruitingNCT02859454Phase 2
10Study of Anti-PD-1 Therapy for HPV-associated Recurrent Respiratory Papilloma Patients With Laryngeal, Tracheal and/or Pulmonary InvolvementRecruitingNCT02632344Phase 2
11New Therapy of Laryngeal Papilloma In ChildrenTerminatedNCT00591305Phase 2
12Bevacizumab for Treatment of Recurrent Respiratory Papillomatosis (RRP)CompletedNCT01020747Phase 1
13Treatment With Cidofovir for Children With Laryngeal Papillomatosis (Warts in the Throat)CompletedNCT00001126Phase 1
14Safety Study of EF-022 in Adults With Recurrent Respiratory Papillomatosis (RRP)Not yet recruitingNCT02854761Phase 1
15Optical Coherence Tomography of the Airway for Lung Cancer or Lung DiseaseWithdrawnNCT00733252Phase 1
16Multi-Center, Randomized Trial of the Pulsed Dye Laser for JORRPCompletedNCT00550914
17Human Papillomatosis Genotyping of Children in ThailandCompletedNCT01304966
18Value of Narrow Band Imaging (NBI) Endoscopy in the Early Diagnosis of Laryngeal Cancer and Precancerous LesionsCompletedNCT02217358
19Human Papillomavirus 6/11 in the Lower Airway of NeonatesCompletedNCT00549250
20Recurrent Respiratory Papillomatosis and Extraesophageal RefluxRecruitingNCT02592902
21Therapeutic Treatment With Human Papillomavirus Quadrivalent Vaccine for Recurrent Respiratory PapillomatosisWithdrawnNCT00829608Phase 0

Search NIH Clinical Center for Recurrent Respiratory Papillomatosis

Genetic Tests for Recurrent Respiratory Papillomatosis

About this section

Anatomical Context for Recurrent Respiratory Papillomatosis

About this section

MalaCards organs/tissues related to Recurrent Respiratory Papillomatosis:

34
Lung, T cells, Testes, Trachea, Spinal cord

Animal Models for Recurrent Respiratory Papillomatosis or affiliated genes

About this section

Publications for Recurrent Respiratory Papillomatosis

About this section

Articles related to Recurrent Respiratory Papillomatosis:

(show top 50)    (show all 364)
idTitleAuthorsYear
1
Multidimensional vocal assessment after laser treatment for recurrent respiratory papillomatosis. (27515839)
2016
2
Human papilloma virus vaccination in patients with an aggressive course of recurrent respiratory papillomatosis. (24964770)
2014
3
Rapid response to systemic bevacizumab therapy in recurrent respiratory papillomatosis. (25289079)
2014
4
Decreased Langerhans Cell Responses to IL-36I^: Altered Innate Immunity in Patients with Recurrent Respiratory Papillomatosis. (24950037)
2014
5
Photodynamic therapy for recurrent respiratory papillomatosis. (24898010)
2014
6
A Case of Recurrent Respiratory Papillomatosis Successfully Removed Via Endoscopic Argon Plasma Coagulation (APC) With No Evidence of Recurrence. (25500852)
2014
7
Pulmonary papillomatosis: a rare case of recurrent respiratory papillomatosis presenting with multiple nodular and cavitary lesions. (25348187)
2014
8
Recurrent respiratory papillomatosis by HPV: review of the literature and update on the use of cidofovir. (25762828)
2014
9
Identical human papillomavirus (HPV) genomic variants persist in recurrent respiratory papillomatosis for up to 22 years. (23204170)
2013
10
Surgical treatment and adjuvant therapies of recurrent respiratory papillomatosis. (24141682)
2013
11
Risk factors for the development and severity of juvenile-onset recurrent respiratory papillomatosis: A systematic review. (24367938)
2013
12
Safety of intralesional cidofovir in patients with recurrent respiratory papillomatosis: an international retrospective study on 635 RRP patients. (23377227)
2013
13
Lung squamous cell carcinoma arising in a patient with adult-onset recurrent respiratory papillomatosis. (23110763)
2013
14
Divergent human papillomavirus associated with recurrent respiratory papillomatosis with lung involvement. (23846273)
2013
15
Narrow band imaging is a new technique in visualization of recurrent respiratory papillomatosis. (22566012)
2012
16
Risk factors of juvenile onset recurrent respiratory papillomatosis in the lower respiratory tract. (23044312)
2012
17
Does food intolerance play a role in recurrent respiratory papillomatosis? (22311847)
2012
18
Recurrent respiratory papillomatosis: a complex defect in immune responsiveness to human papillomavirus-6 and -11. (20553528)
2010
19
Epidemiology of recurrent respiratory papillomatosis. (20553527)
2010
20
High-resolution ultrasound in the evaluation of pediatric recurrent respiratory papillomatosis. (19289702)
2009
21
Pharmacotherapy of recurrent respiratory papillomatosis: an expert opinion. (19284366)
2009
22
Intralesional injection of cidofovir for recurrent respiratory papillomatosis in children. (19193450)
2009
23
Commentary on "Dysplasia in adults with recurrent respiratory papillomatosis: incidence and risk factors". (19708486)
2009
24
Time course of juvenile onset recurrent respiratory papillomatosis caused by human papillomavirus. (18174855)
2008
25
Recurrent respiratory papillomatosis with pulmonary involvement. (18368280)
2008
26
Efficacy of local use of recombinant interferon alpha-2 preparations in combined treatment of recurrent respiratory papillomatosis]. (18833124)
2008
27
Unusual malignant transformation of juvenile recurrent respiratory papillomatosis. (17275567)
2007
28
Identification of HPV DNA in patients with juvenile-onset recurrent respiratory papillomatosis using SYBR Green real-time PCR. (16137771)
2006
29
Recurrent respiratory papillomatosis in children: masquerader of common respiratory diseases. (17079563)
2006
30
Use of the Pediatric Quality of Life Inventory to assess the health-related quality of life in children with recurrent respiratory papillomatosis. (16134343)
2005
31
Efficacy of cidofovir injection for the treatment of recurrent respiratory papillomatosis. (15567056)
2004
32
Recurrent respiratory papillomatosis mimicking retropharyngeal abscess in a Nigerian child. (15171539)
2004
33
2',5'-Oligoadenylate synthetase activity analysis and human papilloma virus typing as prognostic factors in patients with recurrent respiratory papillomatosis. (15550179)
2004
34
Preliminary report of endolaryngeal and endotracheal laser surgery of juvenile-onset recurrent respiratory papillomatosis by Nd:YAG laser and a new fiber guidance instrument. (15243556)
2004
35
Pulsed-dye laser in the treatment of recurrent respiratory papillomatosis of the larynx. (14503089)
2003
36
Molecular events in the progression of recurrent respiratory papillomatosis to carcinoma. (12296755)
2002
37
Pharmacotherapy of recurrent respiratory papillomatosis. (12150688)
2002
38
Recurrent respiratory papillomatosis. (12169123)
2002
39
Topoisomerase alpha II, retinoblastoma gene product, and p53: potential relationships with aggressive behavior and malignant transformation in recurrent respiratory papillomatosis. (11277421)
2001
40
Recurrent respiratory papillomatosis. (10851821)
2000
41
Recurrent respiratory papillomatosis of the larynx: current diagnosis and treatment. (10984775)
2000
42
Risk factors for juvenile onset recurrent respiratory papillomatosis. (9613648)
1998
43
Tracheotomy in children with juvenile-onset recurrent respiratory papillomatosis: the Children's Hospital of Pittsburgh experience. (8546418)
1996
44
Recurrent respiratory papillomatosis. (8869953)
1996
45
Isotretinoin therapy for recurrent respiratory papillomatosis. (8166969)
1994
46
Changes in human papillomavirus typing of recurrent respiratory papillomatosis progressing to malignant neoplasm. (7917213)
1994
47
Human papillomavirus infection in papillomas and nondiseased respiratory sites of patients with recurrent respiratory papillomatosis using the polymerase chain reaction. (8387317)
1993
48
Antibody response to human papillomavirus (HPV) type 11 in children with juvenile-onset recurrent respiratory papillomatosis (RRP). (1314464)
1992
49
Complications of laser surgery for recurrent respiratory papillomatosis. (3688749)
1987
50
Side effects and toxicity of interferon in the treatment of recurrent respiratory papillomatosis. (3674659)
1987

Variations for Recurrent Respiratory Papillomatosis

About this section

Expression for genes affiliated with Recurrent Respiratory Papillomatosis

About this section
Search GEO for disease gene expression data for Recurrent Respiratory Papillomatosis.

Pathways for genes affiliated with Recurrent Respiratory Papillomatosis

About this section

Pathways related to Recurrent Respiratory Papillomatosis according to GeneCards Suite gene sharing:

(show all 24)
idSuper pathwaysScoreTop Affiliating Genes
19.7HLA-DQB1, HLA-DRB1
29.7HLA-DQB1, HLA-DRB1
39.6HLA-DRB1, IL2
49.6HLA-DRB1, IL2
5
Show member pathways
9.5EGFR, IL2
69.5EGFR, IL2
79.5EGFR, IL2
89.2EGFR, HLA-DQB1, HLA-DRB1
9
Show member pathways
9.2HLA-DQB1, HLA-DRB1, IL2
10
Show member pathways
9.2HLA-DQB1, HLA-DRB1, IL2
11
Show member pathways
9.2HLA-DQB1, HLA-DRB1, IL2
129.0HLA-B, TAP1
139.0HLA-B, TAP1
14
Show member pathways
8.9HLA-B, HLA-DQB1, HLA-DRB1
158.9HLA-B, HLA-DQB1, HLA-DRB1
168.9HLA-B, HLA-DQB1, HLA-DRB1
17
Show member pathways
8.7EGFR, HLA-DQB1, HLA-DRB1, IL2
18
Show member pathways
8.6HLA-B, IL2, KIR2DL2
19
Show member pathways
8.4EGFR, HLA-B, HLA-DQB1, HLA-DRB1
208.3HLA-B, HLA-DQB1, HLA-DRB1, IL2
218.2HLA-B, HLA-DQB1, HLA-DRB1, TAP1
22
Show member pathways
7.7HLA-B, HLA-DQB1, HLA-DRB1, IL2, TAP1
23
Show member pathways
7.2HLA-B, HLA-DQB1, HLA-DRB1, IL2, KIR2DL2, TAP1
24
Show member pathways
6.7EGFR, HLA-B, HLA-DQB1, HLA-DRB1, IL2, KIR2DL2

GO Terms for genes affiliated with Recurrent Respiratory Papillomatosis

About this section

Cellular components related to Recurrent Respiratory Papillomatosis according to GeneCards Suite gene sharing:

idNameGO IDScoreTop Affiliating Genes
1MHC class II protein complexGO:004261310.2HLA-DQB1, HLA-DRB1
2clathrin-coated endocytic vesicle membraneGO:003066910.1HLA-DQB1, HLA-DRB1
3transport vesicle membraneGO:003065810.0HLA-DQB1, HLA-DRB1
4endocytic vesicle membraneGO:00306669.8HLA-DQB1, HLA-DRB1
5integral component of lumenal side of endoplasmic reticulum membraneGO:00715569.4HLA-B, HLA-DQB1, HLA-DRB1
6ER to Golgi transport vesicle membraneGO:00125079.3HLA-B, HLA-DQB1, HLA-DRB1
7Golgi membraneGO:00001398.4EGFR, HLA-B, HLA-DQB1, HLA-DRB1

Biological processes related to Recurrent Respiratory Papillomatosis according to GeneCards Suite gene sharing:

idNameGO IDScoreTop Affiliating Genes
1antigen processing and presentation of peptide antigen via MHC class IGO:00024748.9HLA-B, TAP1
2interferon-gamma-mediated signaling pathwayGO:00603338.9HLA-B, HLA-DQB1, HLA-DRB1

Molecular functions related to Recurrent Respiratory Papillomatosis according to GeneCards Suite gene sharing:

idNameGO IDScoreTop Affiliating Genes
1peptide antigen bindingGO:00426058.2HLA-B, HLA-DQB1, HLA-DRB1, TAP1

Sources for Recurrent Respiratory Papillomatosis

About this section
2CDC
6CNVD
10DGIdb
15ExPASy
16FDA
17FMA
25GTR
26HGMD
27HMDB
28ICD10
29ICD10 via Orphanet
30ICD9CM
31IUPHAR
32KEGG
35MedGen
37MeSH
38MESH via Orphanet
39MGI
42NCI
43NCIt
44NDF-RT
47NINDS
48Novoseek
50OMIM
51OMIM via Orphanet
55PubMed
56QIAGEN
61SNOMED-CT via Orphanet
65Tumor Gene Family of Databases
66UMLS
67UMLS via Orphanet